1. Home
  2. HWBK vs ENLV Comparison

HWBK vs ENLV Comparison

Compare HWBK & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HWBK

Hawthorn Bancshares Inc.

N/A

Current Price

$33.68

Market Cap

233.3M

Sector

Finance

ML Signal

N/A

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.96

Market Cap

258.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWBK
ENLV
Founded
1865
2005
Country
United States
Israel
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.3M
258.7M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
HWBK
ENLV
Price
$33.68
$0.96
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$20.00
AVG Volume (30 Days)
6.1K
680.2K
Earning Date
04-29-2026
05-29-2026
Dividend Yield
2.40%
N/A
EPS Growth
31.42
N/A
EPS
3.43
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.07
$0.66
52 Week High
$36.25
$2.10

Technical Indicators

Market Signals
Indicator
HWBK
ENLV
Relative Strength Index (RSI) 55.41 46.08
Support Level $33.28 $0.81
Resistance Level $35.88 $1.19
Average True Range (ATR) 1.07 0.10
MACD 0.18 -0.01
Stochastic Oscillator 83.13 26.28

Price Performance

Historical Comparison
HWBK
ENLV

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company that, along with its subsidiary bank, provides commercial banking for small and mid-sized businesses, including equipment, operating, commercial real estate and SBA loans, and personal banking services such as real estate mortgage lending, installment and consumer loans, certificates of deposit, checking, savings and money market accounts. The company also provides trust services including estate planning, investment and asset management services, brokerage and cash management services. Its primary source of revenue is net interest income derived from lending and deposit taking activities, with much of its business in commercial, commercial real estate development and residential mortgage lending.

About ENLV Enlivex Therapeutics Ltd.

Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.

Share on Social Networks: